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Mycobacteria represent a class of powerful pathogens, including those causing
tuberculosis and leprosy, which continue to be worldwide health challenges. In the last 20
years, an abundance of non-coding, small RNAs (sRNAs) have been discovered in model
bacteria and gained significant attention as regulators of cellular responses, including
pathogenesis. Naturally, a search in mycobacteria followed, revealing over 200 sRNAs thus
far. Characterization of these sRNAs is only beginning, but differential expression under
environmental stresses suggests relevance to mycobacterial pathogenesis. This review
provides a comprehensive overview of the current knowledge of sRNAs in mycobacteria,
including historical perspective and techniques used for identification and characterization.
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INTRODUCTION
Mycobacterial species threaten human health worldwide, caus-
ing infectious diseases such as tuberculosis and leprosy. More
than 140 species have been reported in the gram-positive genus
Mycobacterium, which is divided into three major categories:
Mycobaterium tuberculosis complex, Mycobacterium leprae, and
non-tuberculosis mycobacteria (Jagielski et al., 2014). The major-
ity of species are non-tuberculosis mycobacteria related to non-
pathogenic organisms that live in water or soil. Diagnosis of
non-tuberculosis mycobacteria is complex since they are diverse
in growth temperatures, growth rates, and drug susceptibility,
as well as in clinical relevance (Cosma et al., 2003). M. leprae
and Mycobacterium ulcerans are considered to be highly success-
ful pathogens for causing leprosy and Buruli ulcers, respectively.
However, M. tuberculosis is one of the most common pathogens,
causing tuberculosis in humans and animals. M. bovis and other
five closely related species are also classified within the M. tuber-
culosis complex (shown in Figure 1). Although genome sequences
are highly related among species in the M. tuberculosis complex,
phenotypic properties and hosts vary by species (Cole et al., 1998;
Garnier et al., 2003).
M. tuberculosis is transmitted by aerosol and has evolutionarily
developed various strategies to evade host immune systems. Upon
invasion, M. tuberculosis infects host macrophages. Infection
with attenuated strains of M. tuberculosis causes apoptosis to
macrophages and, consequently, induces adaptive immunity by
recruiting T cells (Behar et al., 2010). However, virulentM. tuber-
culosis might inhibit apoptosis, favoring macrophage necrosis,
and ultimately translocate into the cytosol. Once it can survive
against macrophages, M. tuberculosis starts to quickly replicate
its genome and to infect adjacent cells (Keane et al., 2000;
Wilkinson et al., 2005). It is worth noting that within granuloma,
formed with macrophages, neutrophils, and other immune cells,
M. tuberculosis persists for a long time through various evasion
strategies that can lead to reactivation and, eventually, disease
(Huynh et al., 2011).
The life cycle of M. tuberculosis is unique in that it has
two distinct metabolic states: one is an active replicative state
and the other is a persistent state (Wayne and Sohaskey, 2001).
M. tuberculosis can hide from the host defense mechanism by
non-proliferative persistent states. This is the most contributing
feature of M. tuberculosis for successful survival in host cells and
is referred to as latent infection, but can be reactivated. It has
been known that continuous activation of macrophage is impor-
tant for preventing reactivation of the infection (Flynn et al.,
1998). As such, control of latency in mycobacteria depends on
host responses such as maintenance of granuloma, cytokines, and
chemokines (Flynn and Chan, 2001).
Development of effective drugs against mycobacteria is still an
active area of research. The keys to these efforts lie in the mecha-
nisms of howmycobacteria switch from latent states to aggressive,
disease-causing forms. Recently, sequence-based approaches for
mycobacteria revealed extensive numbers of non-coding RNAs
that include intergenic small RNAs (sRNAs) (Arnvig et al., 2011).
Regulatory RNAs participate in adaptive responses of bacte-
ria against environmental change such as transitions during
pathogenesis. As interest escalates in sRNAs across mycobacte-
rial species, there is a need to compile current knowledge in
the field to unify and focus future work to gain highly sought
medical advantages. The focus of this review is to unfold the his-
tory of sRNA investigation in mycobacterial species. We begin
with a brief narration of sRNA discovery and characterization in
pathogens and then extensively document progress in the search
and characterization of mycobacterial sRNAs in particular.
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FIGURE 1 | Quantitative view of sRNA discovery in mycobacteria by phylogeny. Confirmed sRNAs have been experimentally validated while unconfirmed
sRNAs include unverified computational predictions (Wattam et al., 2014).
SMALL RNAs IN PATHOGENESIS: FROM DISCOVERY TO
TARGETING
Mycobacteria and other pathogens must be highly adaptive to
endure and exploit environmental changes presented by hosts and
their immune responses. Traditionally, various transcription fac-
tors were credited for such cellular reprogramming by turning on
and off expression of relevant genes in response to environmental
stimuli. However, over the last 15 years, understanding of bac-
terial gene expression has expanded beyond the DNA level, now
includingmultiple layers of regulation. Particularly interesting are
sRNAs, typically 50–500 nucleotides in length, known to act as
global regulators of cellular phenotypes (Gottesman and Storz,
2011). Although previously thought to be strictly untranslated
regions, some sRNAs have now been classified as bifunctional,
encoding small peptides (Bobrovskyy and Vanderpool, 2013).
Although our focus is on sRNAs, we have also included limited
discussions of recently identified riboswitches in mycobacteria.
EFFORTS OF sRNA DISCOVERY IN MODEL ORGANISMS HIGHLIGHT
BIOLOGICAL RELEVANCE
The first bacterial sRNA was discovered almost 50 years ago
in Escherichia coli MRE600 (ATCC 29417), but its function
remained unknown for three decades, surfacing shortly after the
complete genome of E. coli K-12 was published (Hindley, 1967;
Blattner, 1997; Wassarman and Storz, 2000). At this time, 10
sRNAs were known in E. coli, mostly discovered by chance dur-
ing studies of individual genetic systems (Wassarman et al., 1999).
However, availability of the fully sequenced E. coli K-12 genome
led to the booming of computational approaches, enabling
large-scale systematic searches of intergenic regions for sRNAs.
In fact, 14 novel sRNAs were reported in a single study of
E. coli in 2001, more than doubling the previously known list
(Argaman et al., 2001). Recent developments in deep sequenc-
ing and high-density microarray technologies have continued to
allow extensive genome-wide studies of sRNAs and their func-
tions. Now, ∼100 sRNAs are known to exist in E. coli and it
has become clear that many are involved in regulating stress
responses (Gottesman et al., 2006; Park et al., 2013). These sRNAs
show significant conservation among other organisms, including
pathogenic bacteria (Hershberg et al., 2003).
Investigations in E. coli have increasingly shifted toward mech-
anistic studies and revealed that regulatory sRNAs typically
function by base-pairing with target mRNAs, thereby alter-
ing transcription, mRNA stability, or translation (Gottesman,
2004). Regulatory sRNAs are generally classified by their genomic
locations with respect to their targets. Cis-encoded sRNAs are
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encoded on the same gene as a target mRNA, but in the oppo-
site, complementary direction, while trans-encoded sRNAs are
located apart from their targets in the genome. Many trans-
encoded sRNAs have been shown to depend on Hfq, an RNA-
binding protein providing stability, in order to function (Zhang
et al., 2003); this has been particularly prevalent in gram-negative
bacteria. Some sRNAs have also been discovered to regulate pro-
teins directly (Romeo et al., 2013). Lastly, riboswitches represent
another class of powerful RNA regulators, typically found in the
5′ untranslated regions (5′ UTRs) of their mRNA targets and
directly responsive to environmental changes. In this category,
RNA thermometers have been found to respond structurally to
changes in temperature to regulate translation (Kortmann and
Narberhaus, 2012). It is worth noting that sRNA classification
continues to present a major challenge with increasing diversity.
With improved mechanistic understanding, there is enormous
interest in inhibiting and/or mimicking expression of natural
sRNA actions to achieve desired changes in targeted genes (Na
et al., 2013; Vazquez-Anderson and Contreras, 2013). Figure 2
summarizes the large-scale sRNA searches, validation experi-
ments, mechanistic and functional studies, and ultimately, tar-
geting efforts. In parallel with such progress in model organisms,
investigations emerged to follow this path in more unique classes
of bacteria.
sRNAs IN PATHOGENS PURSUED FOR MEDICAL ADVANTAGES
The search of sRNAs has sparked special interest in the context
of microbial pathogens. The emergence of studies of sRNAs in
pathogenesis has been supported by the increasing availability
of non-model microbial genomes as well as by the uncovered
roles of sRNAs in environmental stress responses. For instance,
the increasingly well-annotated collection of sRNAs in E. coli has
facilitated discovery of sRNAs in other organisms by computa-
tional homology searches and other bioinformatic tools (Lu et al.,
2011). Combining deep sequencing and transposon mutagenesis,
a recent study identified 89 sRNAs in Streptococcus pneumo-
nia and presented evidence of their importance in pathogenesis
(Mann et al., 2012). Several investigations in non-model organ-
isms have capitalized on the presence of Hfq in some pathogens
to co-immunoprecipite bound RNA targets, followed by deep
sequencing. In a model pathogen, Salmonella enterica serovar
Typhimurium, this approach has revealed 100–200 sRNAs asso-
ciated with Hfq and suggested that Hfq may regulate expression
of more than one-fifth of all mRNAs (Sittka et al., 2008; Chao
et al., 2012; Kröger et al., 2012). Although Hfq-dependent mech-
anisms have not yet been as prevalently detected in gram-positive
bacteria (Romby and Charpentier, 2009), combined computa-
tional and experimental approaches have led to successful sRNA
searches and validation in a variety of gram-positive pathogens
that include Staphylococcus aureus, Listeria monocytogenes, and
S. pneumonia (Papenfort and Vogel, 2010).
The sRNAs discovered in pathogens thus far exert diverse
functions that include regulation of transcription factors, viru-
lence genes, quorum sensing, and outer membrane dynamics in
response to a variety of environmental inputs like temperature,
pH, metabolite, oxidative, and anaerobic stresses. A few examples
FIGURE 2 | sRNA search and characterization. Discovery of sRNAs often
begins with large-scale computational searches followed by experimental
validation. Functional characterization of confirmed candidates identifies their
gene or protein targets and mechanistic studies elucidate their methods of
action. Finally, sRNAs can be used in engineering efforts to develop useful
applications from synthetic elements to medical treatments.
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include the following: in Helicobacter pylori, a bacterial pathogen
that colonizes the human stomach, a cis-encoded 5′ureB-sRNA
enhances truncation of gastric acid acclimation operon ureAB
at neutral pH, but releases its control in acidic environments
to allow survival (Wen et al., 2012). Multiple trans-acting Qrr
sRNAs inVibrio cholerae collaborate with Hfq to regulate quorum
sensing and biofilm formation, important for host transmission
(Zhao et al., 2013). In Shigella flexneri, sRNAs CsrB and CsrC bind
to protein CsrA to regulate carbon metabolism, attachment, and
invasion in pathogenesis (Gore and Payne, 2010). Riboswitches
may regulate 2% of genes in gram-positive pathogens such as
S. aureus and L. monocytogenes in response to metabolites and pH
(Caldelari et al., 2013). An RNA thermometer in L. monocytogenes
inhibits translation of prfA, which encodes a key transcription
factor for virulence (Johansson et al., 2002). Recent reviews pro-
vide more extensive catalogs of sRNA function and mechanisms
in microbial pathogens (Gripenland et al., 2010; Papenfort and
Vogel, 2010; Caldelari et al., 2013) as well as species-specific
discussions for L. monocytogenes (Mellin and Cossart, 2012),
Pseudomonas aeruginosa (Sonnleitner et al., 2012), S. aureus
(Romilly et al., 2012; Tomasini et al., 2014), S. Typhimurium
(Hébrard et al., 2012), and V. cholerae (Bardill and Hammer,
2012).
With increasing resistance of bacteria to traditional antimicro-
bials, sRNAs represent new medical targets to disarm pathogens.
Riboswitches in particular are being pursued as antibiotic targets
due to remarkable specificity and high affinity for their ligands
(Lünse et al., 2014). At this point, one compound targeting the
guanine riboswitch of S. aureus has been shown to successfully
reduce bacterial concentrations in animals after infection (Ster
et al., 2013). Also in S. aureus, sRNA SprX has been shown
to regulate glycopeptide antibiotic resistance through antisense
repression of sporulation protein SpoVG (Eyraud et al., 2014).
This recent literature confirms the promise of sRNAs as new
territory for controlling gene expression in pathogenesis.
sRNAs IN MYCOBACTERIA
Between 2003 and 2006, 30 new mycobacterial species were dis-
covered, bringing the known total to 120 (Tortoli, 2006). These
discoveries have resulted in significant investment toward under-
standing sigma factors and other regulatory proteins as potential
keys to crippling virulence exerted by many of the mycobacte-
rial pathogens (Rodrigue et al., 2006). Some common species
that have been particularly studied are M. tuberculosis, M. leprae,
and M. ulcerans due to their common pathogenesis in humans
(Remus et al., 2003). M. bovis BCG is widely used as a vaccine
against M. tuberculosis and is genetically similar, making it also
a major focus of study (Skeiky and Sadoff, 2006). M. smegma-
tis serves as a model mycobacterial species due to ease of genetic
manipulation, fast growth, and non-pathogenic nature (Shiloh
and DiGiuseppe Champion, 2010).
EARLY COMPUTATIONAL SEARCHES FOR sRNAs IN MYCOBACTERIA
The growing interest in mycobacteria gene regulation has paral-
leled the launching of bioinformatics databases such as Rfam, a
collection of non-coding RNA families that allows classification of
new regulatory RNAs based on sequence and structure homology
in over 200 complete genomes (Griffiths-Jones, 2005). One of
the earliest mycobacterial genomes included in the Rfam database
was M. tuberculosis CDC1551. This led to the prediction of three
initial sRNAs in mycobacteria.
Although important for setting the stage to identify (and val-
idate) the expression of more sRNAs in mycobacteria, the pure
homology-based approach of Rfam limited early studies by hav-
ing to rely on previously identified pools of sRNAs. A second type
of bioinformatics search, sRNAPredict2, which predicted sRNAs
by co-localization of genetic features common to sRNA-encoded
regions, was also applied to the prediction of sRNAs in mycobac-
teria. This algorithm identified 56 new sRNAs in M. tuberculosis
CDC1551, a much higher number that did not correspond to the
three previously annotated by Rfam (Livny et al., 2006). Although
these early computational efforts lacked consistency, most impor-
tantly, they provided evidence that multiple genomic regions
could encode sRNAs in mycobacteria.
As we unfold major themes of the sRNA story in mycobac-
teria, refer to Figure 3 for the chronological alignment of these
events. Also, note that Supplementary Table S1 lists all con-
firmed sRNAs in mycobacterial species to date along with char-
acteristic data such as genomic location, differential expression,
and known homology between species. Amazingly, more than
half of the M. tuberculosis H37Rv sRNAs have been confirmed
since the most recent sRNA review of this species (Arnvig and
Young, 2012). Unconfirmed sRNA predictions are not included
in Supplementary Table S1, but are quantified in Figure 1, a view
of sRNA discovery by phylogeny within mycobacterial species,
and listed in Supplementary Table S2. We use a universal sRNA
nomenclature reported in Lamichhane et al. (2013) throughout
this review to allow convenient cross-reference among the sRNAs
being discussed.
EARLY EXPERIMENTAL INDICATION OF NON-CODING RNA
REGULATORS
One of the first experimental indications of the presence
of responsive regulatory RNA elements in mycobacteria was
obtained fortuitously by studies that aimed to understand the
role of vitamin B12 in the growth inhibition of M. tubercu-
losis CD1551. In the context of this work, a B12 riboswitch
(ncMT2183Ac) was found to regulate transcription of metE, a
gene encoding methionine synthase (Warner et al., 2007). As pre-
viously suggested for other bacteria, this exposed potential for
using antibiotics and/or small molecules to target riboswitch gate-
keepers of essential genes expressed during pathogenesis. Only a
couple of years after this study, tiling array analysis of M. leprae
Thai-53 infected rats revealed high expression of 68 non-coding
regions throughout the genome, representing 32.5% of the total
relative expression profile (Akama et al., 2009). Although this data
could have been interpreted as simply transcriptional degradation
under these host conditions, earlier data in other mycobacterial
species encouraged the alternative: that an abundance of sRNAs
was expressed in this strain of M. leprae.
To date, riboswitch motifs remain largely uncharacterized in
M. tuberculosis and further analysis of existing datasets could lead
to confirmation of these important regulators. For example, two
Mbox riboswitches (also called Ykok leaders) are predicted in
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FIGURE 3 | Timeline of sRNA developments inmycobacteria. Progress inM. tuberculosis (upper) and other mycobacterial species (lower) are shown in parallel
in chronological order. The surge of studies in the last few years suggests momentum toward further discovery, mechanistic studies, and medical applications.
M. tuberculosis: one located in the 5′ UTR of a hypothetical pro-
tein induced during Mg-starvation and the other in the 5′ UTR
of a predicted magnesium transporter (Arnvig and Young, 2012).
It has been hypothesized that these regulatory elements act simi-
larly to their Bacillus subtilis homologs by inhibiting transcription
of the downstream gene when bound to Mg2+.
CONFIRMATION OF THE FIRST sRNAs IN MYCOBACTERIA
The first complete experimental confirmation of sRNAs in
mycobacteria was published in 2009, revealing five trans-encoded
and four cis-encoded sRNAs in M. tuberculosis H37Rv (Arnvig
and Young, 2009). These sRNAs were discovered by screen-
ing cDNA libraries of low molecular weight RNAs (20–75
nucleotides) in exponential and stationary growth phases. All
reported sRNAs (see Supplementary Table S1) were confirmed
by northern blotting analysis and their transcriptional ends were
mapped by 5′ and 3′ RACE (Arnvig and Young, 2009). The
functional significance of these sRNAs was reported in the con-
text of oxidative stress, where M. tuberculosis H37Rv cells were
cultured to exponential phase and then H2O2 was added to
10mM for 1 h. Under these specific stress conditions, sRNAs
B55 (ncRv10609AA), F6 (ncRv10243A), and ASpks (ncRv2048A)
showed differential expression of 2-fold or greater (relative to
their unstressed state). F6 was similarly expressed under pH stress,
in which exponentially growing cells were suspended in acidi-
fied medium of pH 5.0 and allowed to grow for another 24 h.
These conditions mimic the changing macrophage environment
during active infection from pH ∼6.2 to ∼5.0 and during the
accumulation of free fatty acids from the host (Vandal et al.,
2009).
Evidence of the functional role of F6 (later reported as Mcr14)
indirectly resulted from studies of the SigF regulon in M. tuber-
culosis H37Rv, where this sigma factor was shown to regulate
its transcription (Hartkoorn et al., 2012). Furthermore, slow cell
growth of H37Rv had been shown both upon F6/Mcr14 overex-
pression (under strong rrnB promoter ofM. smegmatis) and upon
induction of SigF (presumably due to its ability to up-regulate
F6). It has also been suggested that some SigF binding sites are
not associated with mRNA transcripts and are likely to bind to
sRNAs not yet annotated.
Interestingly, none of the first experimentally confirmed
sRNAs were predicted computationally. This discrepancy can be
rationalized by the computational challenge presented by the
uniqueness of the promoters and terminators in M. tubercu-
losis. Furthermore, the genomes of mycobacterial species are
much higher in GC content (∼65%) relative to other model
bacteria (e.g., E. coli, GC content of ∼50%) where earlier com-
putational sRNA searches had been successful (DiChiara et al.,
2010). For these reasons, one question of even more impor-
tance in mycobacterial species has been: How many compu-
tationally predicted sRNAs represent false positives? We have
reported mixed results with predictions made by SIPHT and
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WU-BLAST (DiChiara et al., 2010; Tsai et al., 2013; Cho et al.,
2014).
A RISING NUMBER OF NEWLY IDENTIFIED sRNAs
The year following the first report of sRNAs in M. tuberculosis,
a new approach coupled low-molecular cloning and computa-
tional methods in M. bovis BCG, M. tuberculosis H37Rv, and
M. smegmatis MC2155 (DiChiara et al., 2010). The cloning in
these model strains began with construction and screening of
cDNA libraries from both log and stationary phases, yielding
116 sRNA candidates. After elimination of rRNA, tRNA, and
other annotated elements, 60 candidates were selected and tested
in M. bovis by northern blotting analysis, leading to 19 con-
firmed sRNAs (listed in Supplementary Table S1). In parallel, the
computational approach began with predictions by the SIPHT
program, a high-throughput progeny of sRNAPredict2, which
identified 144 sRNA candidates (Livny et al., 2008). The 67 that
showed partial conservation in other mycobacterial species were
tested by northern blotting in M. bovis and 21 additional sRNAs
were confirmed (listed in Supplementary Table S1). Three sRNAs
were confirmed by both cloning and computation methods,
bringing the total to 37. Mcr6 (ncBCG3782Ac), Mcr14/Mpr13
(ncBCG10281A), and Mpr19 (ncBCG0526A) had been identified
by previous studies inM. tuberculosisH37Rv as F6 (ncRv10243A),
Mpr19 (ncRv13660Ac), and B11 (ncRv13660Ac), respectively.
A unique approach taken by this study was to check for homologs
of confirmed M. bovis sRNAs by using the same probes in north-
ern blotting analysis in additional species. With this method,
20 new sRNAs were confirmed in M. tuberculosis H37Rv and
15 in M. smegmatis MC2155. The higher number identified and
verified in M. tuberculosis (relative to M. smegmatis) is not sur-
prising given the shorter evolutionary distance between M. bovis
and M. tuberculosis relative to the distance between M. bovis and
M. smegmatis, as shown in Figure 1 (Devulder, 2005). Only three
M. bovis sRNAs were identified by both cloning and compu-
tational methods and only three M. tuberculosis H37Rv sRNAs
had been previously discovered, conveying the importance of
combining various approaches.
A follow-up study (Tsai et al., 2013) used the same SIPHT
predictions in M. bovis BCG and M. smegmatis to test the
remaining candidates. As part of that work, 23 additional novel
sRNAs were confirmed by northern blotting analysis in M. bovis
BCG and 17 in M. smegmatis MC2155 (listed in Supplementary
Table S1). With M. smegmatis as the primary species of inter-
est, this approach revealed nine homologs in M. bovis and four
in M. tuberculosis (listed in Supplementary Table S1). By analy-
sis of existing ChIP-seq data from M. tuberculosis (Galagan et al.,
2012), at least four sRNA 5′ ends were matched with otherwise
uncharacterized transcription factors. From this series of stud-
ies, a stronger connection between pathogenesis and differential
expression of sRNAs in mycobacteria emerged. A powerful exam-
ple was the differential expression of Mcr11, an sRNA between
two cAMP metabolism genes, in M. bovis (ncBCG1323Ac) and
M. tuberculosis (ncRv11264Ac) under host-like conditions, such
as low pH (5.5) and hypoxia (1.3% O2 + 5% CO2). Perhaps most
importantly, this study proposed the use of conservation analysis
across multiple mycobacterial species to begin posing questions
related to the potential pathogenic vs. housekeeping functions
of the newly uncovered sRNAs. New questions were raised for
future studies that included: Which sRNAs are uniquely con-
served among the pathogenic species? Do conserved sRNAs by
sequence perform the same function across phylogeny? This study
also was one of the first to adhere to the recommended annotation
(also being used in this review).
IMPLICATIONS OF A MISSING Hfq HOMOLOG TO THE SEARCH AND
CHARACTERIZATION OF sRNAs
A challenge in mycobacterial sRNA studies has been the lack
of identification of an Hfq homolog, preventing Hfq co-
immunoprecipitation approaches for sRNA discovery. The lack
of Hfq has also raised questions about alternative chaperones or
inherent stability granted by C-rich stretches observed in the ris-
ing number of confirmed sRNAs. It is important to note that
in 2012, a review of non-coding RNAs specific to M. tuberculo-
sis (Arnvig and Young, 2012) posed the notion that hypothetical
protein Rv2367 of unknown function could serve as a poten-
tial RNA chaperone alternative to Hfq based on its homology to
YbeY, a protein in Sinorhizobium meliloti shown to perform cer-
tain Hfq-like functions (Pandey et al., 2011). Rv2367, however,
has significantly lower expression than Hfq in E. coli, strength-
ening the argument that C-rich stretches of mycobacterial sRNAs
may provide enough stability to the sequences without the need
of a functionally-equivalent chaperone.
It is also worth noting that a novel method has exploited
the conserved sRNA-binding ability of E. coli Hfq by express-
ing it in M. smegmatis and using co-immunoprecipitation
and deep sequencing to identify sRNAs (Li et al., 2012). The
approach found 12 trans-encoded and 12 cis-encoded sRNAs con-
firmed by northern blotting analysis and mapped by 5′ RACE
(listed in Supplementary Table S1). Interestingly, five of the
cis-encoded sRNAs are immediately upstream of known trans-
posases. Some of the identified M. smegmatis sRNAs also show
homology to regions in other mycobacteria, especially in non-
pathogenic species known for rapid growth, suggesting that
these sRNAs could be involved in enhancing growth efficiency.
All of them showed differential expression between exponential
and stationary phases. Homologs to previously identified sRNAs
C8 (ncRv13722Ac) and B11 (ncRv13660Ac) in M. tuberculosis
H37Rv (Arnvig and Young, 2009) were also identified inM. smeg-
matis (ncMSMEG16286A and ncMSMEG6172Ac, respectively).
Consistent with previous studies, multiple sizes of individual
sRNAs were also observed here, raising questions about how
sRNAs are processed and the potential role of sigma factors in
mycobacteria. Although, sRNA regulation of transposition has
been studied in E. coli, mechanisms in mycobacteria remain
largely obscure.
AN EXPLOSION IN sRNA IDENTIFICATION GUIDED BY
HIGH-THROUGHPUT SEQUENCING
Transcriptome profiling of M. tuberculosis H37Rv revealed high-
density reads in intergenic regions (other than from those
encoding rRNAs and tRNAs), representing a potential abun-
dance of sRNAs (Arnvig et al., 2011). In fact, 28% of the
total transcriptome represented intergenic reads, consistent with
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other organisms. The most highly expressed sRNA detected
in exponential phase was MTS2823 (ncRv13661A), which
also increased 10-fold in stationary phase. Overexpression of
MTS2823 up-regulated two genes (Rv2035, a potential activa-
tor of HspG, and Rv3229c, a fatty acyl desaturase) and down-
regulated a large set of about 300 genes, including a methyl
citrate synthase that is reduced by 15-fold. It was suggested
that MTS2823 may have functional homology with 6S RNA,
but the mechanism remains unclear. MTS1338 (ncRv1734A) was
also induced in stationary phase, depending at least partially
on the DosRS hypoxia-responsive regulator system. In the same
study, significant accumulation of sRNAs was observed in infected
lungs of mice, especially MTS2823, MTS0997 (ncRv11264Ac),
and MTS1338, suggesting potential involvement in pathogenesis.
Later work showed that M. tuberculosis H37Rv sRNAs MTS0479
(ncRv10609AA) and MTS1338 are not present in M. avium
(Ignatov et al., 2013). Since M. avium is conditionally pathogenic
andM. tuberculosisH37Rv is highly pathogenic, these two sRNAs
could be key players in pathogenesis. These studies marked an
important step in the successful application of high-throughput
genome-wide sequencing technology for sRNA identification as
well as in establishing direct medical relevance to pathogenesis by
use of mouse models.
The next genome-wide search in M. tuberculosis examined
strain CDC1551 (Pelly et al., 2012). Twelve sRNA candidates were
identified; four of the intergenic candidates were novel sRNAs and
the other eight all contained sequences within the region between
genes MT1302 and MT1303, which showed homology to a sin-
gle sRNA identified in M. bovis BCG. This abundant sRNA was
labeled ncrMT1302 (ncMT1130Ac) and examined further under
nitric oxide (250μMdiethylenetriamine nitric oxide adduct), low
pH (5.5), and limited nutrition (PBS + 0.05% Tween 80) stresses
for 6 h during exponential phase. Expression levels of ncrMT1302
were reduced in all cases, most dramatically at low pH with a
7-fold reduction. To detect antibiotic responses, total RNA was
exposed to the minimal inhibitory concentrations (MIC) of iso-
niazid or rifampicin for 3 h before ncrMT1302 expression was
observed by northern blot analysis. Isoniazid showed no sig-
nificant effect, but rifampicin caused reduction in ncrMT1302
expression. MT1302 encodes an adenylyl cyclase that converts
ATP to cAMP and MT1303 encodes a hypothetical protein that is
transcribed in the presence of cAMP in low-oxygen conditions. In
a strain lacking the cAMP-producing gene MT1302, ncrMT1302
was less abundant and no longer differentially expressed under
stress. This sRNA also contains a potential binding site for tran-
scription factor Cmr (cAMP and macrophage regulator) and was
confirmed in the lungs of mice during infection.
A new method for sRNA identification involved building an
effective target genome (ETG) and then combining transcriptome
data with comparative genomics (Pellin et al., 2012). The target
genome in this case included only intergenic regions, thus cod-
ing regions were removed before the dataset was filtered further
by RNA-seq reads and conservation between genomes. Applied
to M. tuberculosis H37Rv, this approach generated a list of 1948
candidate sRNAs, which included six of the nine identified by
Arnvig and Young (Arnvig and Young, 2009). This method also
predicted 17 of the 37 found in M. bovis BCG by DiChiara et al.
(2010). All candidates identified were compared with the Rfam
database and many showed homology with known families. Most
notably, Rfam matches included SAM-IV, TPP family, and Ykok
leader riboswitches.
In addition to large scale transcriptomic studies, a com-
parative analysis of 31 genomes of mycobacteria and related
actinomycetes by sequence and gene expression allowed identi-
fication of 50 predicted non-coding RNAs (McGuire et al., 2012).
This set of genomes included 8 strains of the M. tuberculosis
complex (M. tuberculosis and M. bovis) and 11 other mycobac-
teria including M. leprae, M. ulcerans, M. marinum, M. avium,
and M. smegmatis. Four more novel sRNAs were confirmed
by northern blotting analysis in M. tuberculosis H37Rv (listed
in Supplementary Table S1) with homology in M. smegmatis
MC2155 (listed in Supplementary Table S2). This massive dataset
highlighted the evolutionary importance of lipid metabolism and
its regulation among these species in regards to pathogenesis.
Figure 1 illustrates the presence of sRNAs across mycobacterial
phylogeny.
INCREASED STUDIES BEYONDM. TUBERCULOSIS,M. BOVIS, AND
M. SMEGMATIS
By cloning and homology search, four intergenic sRNAs have
been directly detected in M. avium subsp. avium TMC724 (listed
in Supplementary Table S1) (Ignatov et al., 2012). Because the
genome of this strain is not available, the sRNAs were mapped
by RACE to the M. avium hominissuis 104 genome. A follow-
up study of M. avium TMC724 predicted 86 cis-encoded sRNAs,
10 trans-encoded sRNAs, and five riboswitches, which are listed
in Supplementary Table S2 (Ignatov et al., 2013). The predicted
riboswitches included three Ykok leaders (Mg2+ sensing) and
one SAM-IV (S-adenosylmethionine sensing); both types had
been previously spotted in M. tuberculosis H37Rv. The trans-
encoded sRNAs showed conservation with M. tuberculosis and
M. ulcerans. Of six intergenic sRNAs, only igMAV_1034-1035
(ncMAV11034Bc) had no homolog in M. tuberculosis. The two
mostly highly expressed sRNAs in this study, igMAV_0468-0469
(ncMAV10468Ac) and igMAV_0469-0470 (ncMAV10469A), were
tested in mice genetically susceptible and genetically resistant
to M. avium infection. The resistant mice showed much lower
expression of these sRNAs in lung tissue relative to non-resistant
mice. However, theM. tuberculosis homolog to igMAV 0468-0469,
sRNAMTS2823 (ncRv13661A), was shown to accumulate to high
levels in the lungs of mice resistant to tuberculosis, potentially
indicating a difference between M. avium and M. tuberculosis in
the mouse infection model.
In addition to increased studies in M. avium, transcriptome
analysis has been recently applied to the search of regulatory
sRNAs in M. marinum during exponential and stationary phases.
In these studies, it was observed that read-rich antisense and
intergenic regions accounted for 23%of the total transcriptome in
exponential phase and 40% in early stationary phase (Wang et al.,
2013). A very highly expressed sRNA candidate, MMAR_5556, is
homologous toMTS2823 (ncRv13661A), previously shown as the
most abundant sRNA inM. tuberculosisH37Rv. Three sRNAs pre-
dicted were matched with Rfam as a TPP family riboswitch, an
ALIL pseudoknot, and a 6C RNA.
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EFFORTS TO UNIFY RAPIDLY INCREASING KNOWLEDGE IN THE FIELD
As focus begins to shift to the functional characterization of
mycobacterial sRNAs, the need to unify all research efforts in
cross-species discovery and characterization has become more
prevalent. A challenge highlighted by increased sRNA discov-
ery studies across mycobacterial species was the lack of uni-
versal sRNA nomenclature across the emerging literature. For
instance, F6, Mcr14, Mcr13, and MTS0194 represent the same
sRNA (ncRv10243A). To address this issue, an official recom-
mendation for systematic annotation of non-coding RNA in
mycobacteria was recently published (Lamichhane et al., 2013).
The suggested format includes species designation and genomic
location. For example, an sRNA identified within the open read-
ing frame (ORF) of gene Rv1234 in M. tuberculosis H37Rv would
be labeled “ncRv1234” if on the plus strand or “ncRv1234c” if on
the minus strand. If the sRNA were located completely between
ORFs, it would carry the number of the upstream ORF and a “1”
would be added in front to indicate an intergenic region, such as
“ncRv11234” or “ncRv11234c.” Finally, the direction of the sRNA
should be indicated by “A” if in the plus strand orientation or
“B” if in the minus strand orientation, such as “ncRv1234A” or
“ncRv11234B.” In this way, the sRNA names would give useful
information and be consistent between studies. We have adhered
to this nomenclature in this review, where we have taken the
challenge to begin consolidating all mycobacterial sRNAs.
FROM DISCOVERY TO FUNCTIONAL CHARACTERIZATION
As seen above, cis-regulatory element functions are suggested by
their locations relative to known ORFs. Although not greatly
exploited in mycobacterial species, bioinformatics tools such as
TargetRNA have been used in Salmonella and Listeria pathogens
to predict sRNA interactions in silico (Tjaden, 2008;Wurtzel et al.,
2012; Yu and Schneiders, 2012). Still, experimental methods are
necessary to confirm these suggested interactions. Efforts to elu-
cidate sRNA functions have traditionally relied on microarray for
transcriptome analysis under various stress conditions or under
sRNA overexpression or deletion. Even with the development of
high-density tiling arrays, this technology is becoming obsolete in
favor of increasingly affordable high-throughput methods.
The sRNA candidates identified with the ETG transcriptome
and comparative genome approach in M. tuberculosis H37Rv
(Pellin et al., 2012) have been examined by microarray to con-
firm expression (Miotto et al., 2012). Of the 1373 predicted in
exponential phase, 258 were confirmed by microarray includ-
ing 22 intergenic, 84 in 5′ or 3′ UTRs (including potential
riboswitches), and 152 antisense sRNAs. Twenty of 23 candidates
tested were confirmed by northern blot analysis and mapped by
5′ RACE (listed in Supplementary Table S1). A computational
analysis of pathway regulation showed that membrane-bound
proteins were especially likely subjects of antisense regulation.
Additionally, about 100 sRNAs < 50 nucleotides were detected,
but the functions of these micro-sized RNAs are unknown.
In an effort to define genomic regions required for growth
in M. tuberculosis H37Rv, two 100,000-clone libraries were gen-
erated by high-density transposon mutagenesis (Zhang et al.,
2012). Transposon-mapping probes were developed and ampli-
fied to allow deep sequencing of their neighboring genomic
regions, mapping insertion sites. Sliding window analysis was
used to scan the genome for insertion site counts in order to
find underrepresented regions, likely to be essential in func-
tion. The search identified 25 intergenic regions as essential
for growth including tmRNA, the RNA component of RNaseP,
and 19 regions with unknown function. One limitation of
this study was that the smallest search window for inter-
genic regions was 250 basepairs, preventing detection of shorter
sRNAs. This study showed consistency with a previous microar-
ray approach (Sassetti et al., 2003), but provided much higher
resolution.
Perhaps the most currently favored high-throughput alter-
native to microarray is ChIP-seq, which combines traditional
chromatin immunoprecipitation with deep sequencing to map
in vivo DNA-protein interactions across the genome. Advantages
of ChIP-seq over microarray include single-nucleotide resolution
(compared to 30–100 bp resolution for microarray), low cost, and
small amount of required DNA (10–50 ng for ChIP-seq compared
to>1μg for microarray) (Park, 2009).
By combining ChIP-seq andmicroarray data, sRNA regulation
networks were predicted for M. tuberculosis H37Rv and are con-
sistent with previously known sRNA functions (Peterson, 2013).
The context likelihood of readiness (CLR) algorithm was used to
infer the networks and false positives were filtered out by compar-
ison to overexpression microarray data. As a proof-of-concept,
M. tuberculosis was grown under hypoxia stress over 14 days
and examined by microarray, revealing 58 trans-acting sRNAs
significantly induced or repressed, and the sRNA hypoxia regu-
latory network was successfully generated. These networks can
be visualized in a spider web fashion to clearly show direct and
indirect connections. Sigma factor SigH was predicted to regulate
sRNA ncRv13596A, linking hypoxia and cholesterol metabolism,
and DosR was predicted to regulate ncRv1102A and ncRv1734A,
linking hypoxia also to changing phthiocerol dimycocerosates.
SigF and ncRv10243c were associated with the cell wall and
plasmamembrane, consistent with E. coli homologs with a known
mechanism.
In other organisms, ultraviolet crosslinking and immuno-
precipitation (CLIP) has been used to detect RNA-protein
binding sites in vivo with deep sequencing. Photoactivatable
ribonucleoside-enhanced CLIP (PAR-CLIP) allows single cross-
linked nucleotide resolution, but requires cells to incorpo-
rate photoactivatable nucleoside analogs like 4-thiouridine or
6-thioguanosine (König et al., 2012). CLIP-seq provides strand-
specific data unlike ChIP-seq (Wang et al., 2014). At this
point, CLIP has been most used to determine alternative splic-
ing mechanisms in mammalian systems (König et al., 2014).
Mycobacterial sRNA studies may pursue PAR-CLIP or other
CLIP variations to obtain strand-specific binding insight in
the future. Other technologies are available for characteriza-
tion of discovered sRNA interactions including reporter gene
fusions (gfp, lacZ, luc), in vitro RNA-RNA footprinting, and
in vitro toeprinting (Podkaminski et al., 2014). In particular,
toeprinting has been successful in characterizing sRNAs that
negatively regulate their targets. With these techniques, mycobac-
terial studies will benefit from precedents set in widely studied
organisms.
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sRNA CHARACTERIZATION FOR MEDICAL APPLICATIONS
Recent studies have employed high-throughput sRNA charac-
terization methods to analyze medical problems. Remarkably,
in response to an epidemic of bovine tuberculosis in Great
Britain, four field strains of M. bovis were processed by sequenc-
ing, microarray, transcriptome analysis, RACE, and recombinant
DNA technology to observe effects of synonymous point muta-
tions (sSNPs) (Golby et al., 2013). Unexpectedly, some of these
sSNPs of coding strands resulted in expression of antisense tran-
scripts on the opposite strand, challenging the definition of “silent
mutation” and suggesting the potential of sRNAs in these loci. A
high-density tiled microarray was designed to examine changes in
expression of non-coding RNAs across the genomes. Transcripts
were considered confirmed sRNAs only if detected by two ormore
overlapping probes. In this way, 26 sRNAs were found (listed
in Supplementary Table S1). Seven intergenic transcripts were
located within the direct repeat (DR) locus, a suggested CRISPR
locus. One antisense sRNA as_Mb1618c (ncMb1618Ac) overlaps
with a predicted secretory lipase gene was only present in strain
1121/01. Similarly, as_Mb1914c (ncMb1914Ac) and as_echA21
(ncMb3803Ac) were only expressed in strain 2451/01, encoded
antisense to a short chain dehydrogenase and an enoyl-CoA
hydratase, respectively. These sRNAs unique to individual strains
may be evolutionary adaptations to different environments.
The H56 vaccine for primate M. tuberculosis includes Rv2660c
as an antigen, which overlaps with sRNA ncRv12659 (Houghton
et al., 2013). The Rv2660c locus was originally selected as an
antigen due to its enhanced transcription during M. tuberculo-
sis H37Rv starvation, but by RNA-seq and northern blotting,
the sRNA was shown to be the true cause of this increased
expression. Because ncRv12659 accumulates to high levels during
infection, it can serve as a potential biomarker. Still, the mech-
anism by which ncRv12659 leads to this increased transcription
is unknown. Interestingly, only the 5′ portion of ncRv12659 was
detected during infection, raising questions about sRNA process-
ing. Truncation could be the result of premature termination or
degradation of an unstable 3′ portion.
THE PATH FORWARD
The surge of sRNA studies in mycobacteria in the last 3 years
favors continued momentum toward medical applications. Still,
many species have yet to be studied and a large number of sRNAs
remain uncharacterized. High-throughput experimental meth-
ods would aid in bridging the gap between the ever-growing pool
of predicted sRNA candidates and the set of confirmed molecules
with known functions. Work remains to be done computation-
ally and experimentally to map the complex sRNA control net-
works of pathogens. Future work could employ ChIP-seq to map
gene regulatory networks and truly begin addressing the need to
understand the functional role of these sRNAs in mycobacterial
species. Likewise, increased phenotypic data for individual sRNA
knockout or overexpression strains could enhance efforts to map
sRNA regulatory networks.
Despite the limited number of functionally characterized
sRNAs in mycobacteria, the door is already open for exploiting
known sRNA functions in pathogens to gain medical advan-
tages. The development of antibiotics to cripple sRNA-enabled
virulence could be a powerful, new approach, especially as
microbes show resistance to conventional compounds. In partic-
ular, abundant and uniquely expressed sRNAs during infection
could serve as useful biomarkers or as therapeutic targets.
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